The Scientist

» grant review and immunology

Most Recent

image: Troubled Grant Giver Can Resume

Troubled Grant Giver Can Resume

By | November 4, 2013

Texas lawmakers lifted a ban on a taxpayer-funded research organization to dole out grants.

0 Comments

image: Impact Forecasts Cloudy

Impact Forecasts Cloudy

By | October 31, 2013

Current models do a poor job of predicting the impact individual scientists will have, according to a study.

0 Comments

image: It’s in the Genes

It’s in the Genes

By | October 24, 2013

Researchers find strong correlations between the composition of the human microbiome and genetic variation in immune-related pathways.

4 Comments

image: Drug Widens Immunity to Flu

Drug Widens Immunity to Flu

By | October 20, 2013

An immune suppressive drug can unexpectedly help immunized mice fight off many strains of flu.

0 Comments

image: Science, Stalled

Science, Stalled

By | October 11, 2013

A salmonella outbreak threatens as the FDA, CDC, and USDA limp along, national laboratories are on the brink of closing, and some patients are admitted to the NIH hospital.

1 Comment

image: Week in Review: September 30–October 4

Week in Review: September 30–October 4

By | October 4, 2013

Scientists feel the shutdown’s sting; dogs comprehend human cues; lab-grown secretory glands; whether online comments help or hurt science

0 Comments

image: Federally Funded Researchers Fear Shutdown Delays

Federally Funded Researchers Fear Shutdown Delays

By | October 2, 2013

As the US government shutdown enters its second day, scientists who rely on federal grants to continue their work and support their staffs and students express frustration. 

0 Comments

image: Opinion: Reviewing Reviewers

Opinion: Reviewing Reviewers

By | July 19, 2013

Science needs a standard way to evaluate and reward journal reviewers.

1 Comment

image: Week in Review, July 8–12

Week in Review, July 8–12

By | July 12, 2013

Editor accused of fraud leaves post; the good and the bad of gut microbiota; bacterial gene shuffle; legal restrictions hamper illicit drug research; antibodies and autism

0 Comments

image: Side-Chain Theory, circa 1900

Side-Chain Theory, circa 1900

By | July 1, 2013

Paul Ehrlich came up with an explanation for cellular interactions based on receptors, earning a Nobel Prize and the title "Father of Modern Immunology"—only to have his theory forgotten.

3 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham